Fig. 1: Swimmer plot of individual patient responses. | Nature Communications

Fig. 1: Swimmer plot of individual patient responses.

From: Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort

Fig. 1

Colors of bars represent best overall response (green, partial response; blue, stable disease; red, progressive disease). Black filled square marks the date of response onset; yellow filled square represents the date of progression or death; gray filled arrow denotes that the patient is currently active on study; star denotes a RAS gene wild-type patient; and # represents a patient with no liver metastasis.

Back to article page